Assessing the Value of Next-Generation Sequencing Technologies: An Introduction

Value Health. 2018 Sep;21(9):1031-1032. doi: 10.1016/j.jval.2018.06.012. Epub 2018 Aug 23.

Author

Kathryn A Phillips¹

Affiliation

¹ Department of Clinical Pharmacy, UCSF Center for Translational and Policy, Research on Personalized Medicine (TRANSPERS), UCSF Philip R. Lee Institute for Health Policy, UCSF Helen Diller Family Comprehensive Cancer Center University of California San Francisco, San Francisco, CA, USA. Electronic address: kathryn.phillips@ucsf.edu.

PMID: 30224105
DOI: 10.1016/j.jval.2018.06.012

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

High-Throughput Nucleotide Sequencing / methods
High-Throughput Nucleotide Sequencing / trends*
Humans

Grants and funding

R01 HG007063/HG/NHGRI NIH HHS/United States